Masaru Inagaki

Growth inhibition by transforming growth factor beta (TGF-beta) type I is restored in TGF-beta-resistant hepatoma cells after expression of TGF-beta receptor type II cDNA.

Masaru Inagaki, Aristidis Moustakas, Herbert Y. Lin et al. · Proceedings of the National Academy of Sciences · 1993 · 188 citations · Full text

T-regulatory Cell, Immunology, Cell Proliferation +20

Genetic progression and heterogeneity in intraductal papillary-mucinous neoplasms of the pancreas.

Hiroaki Fujii, Masaru Inagaki, S. Kasai et al. · PubMed · 1997 · 124 citations

Clinical evaluation of a pasteurized factor XIII concentrate administration in Henoch-Schönlein purpura

Hiromu Fukui, Hidekazu Kamitsuji, T Nagao et al. · Thrombosis Research · 1989 · 56 citations

Translational Medicine, Henoch-schönlein Purpura, Clinical Chemistry +2

Impact of lymph node dissection on clinical outcomes of intrahepatic cholangiocarcinoma: Inverse probability of treatment weighting with survival analysis

Yuzo Umeda, Toshiharu Mitsuhashi, Toru Kojima et al. · Journal of Hepato-Biliary-Pancreatic Sciences · 2021 · 41 citations · Full text

Hyperbilirubinemia as a predictor of severity of acute appendicitis

Masaaki Akai, Kazuhide Iwakawa, Yasui Yuichi et al. · Journal of International Medical Research · 2019 · 34 citations · Full text

Complicated Appendicitis, Clinical Epidemiology, Gastroenterology +12